NEW YORK, Nov. 10, 2016 /PRNewswire/ -- This report on the global cytology and HPV testing market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global cytology and HPV testing market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements. Cytology and HPV testing kits are used extensively in PAP testing and cervical cancer testing. This report on the cytology and HPV testing market analyzes the current and future prospects of the market. An elaborate executive summary includes the market snapshot demonstrating overall information on various segments and sub-segments. This section also provides the complete information and data analysis of the cytology and HPV testing market with respect to the leading market segments based on product and services, and geography.The market overview section of the report includes qualitative analysis of the overall cytology and HPV testing market including the determining factors and the market dynamics such as drivers, restraints, and opportunities, along with Porter's Five Forces Analysis. This section of the report also provides market attractiveness analysis with thorough analysis of the overall competitive scenario in the global overall cytology and HPV testing market. In addition, epidemiology of HPV and cervical cancer has been provided which gives incidence rate, annual number of new cases, and mortality of HPV-related cervical cancer in different countries. The competitive scenario between different market players is evaluated through market share analysis. These factors are anticipated to help the market players to take strategic decisions in order to strengthen their positions and increase their shares in the global market.